Reveal LINQ vs ACUSON Sequoia Select Diagnostic Ultrasound System
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, the Medtronic Reveal LINQ, is an implantable cardiac monitor that uses AI to continuously record ECG and detect arrhythmias over extended periods. In contrast, Tool B, the Siemens ACUSON Sequoia Select, is an AI-powered diagnostic ultrasound system designed for real-time imaging of cardiac structures and other organs. While both leverage AI in cardiology, they serve distinct diagnostic purposes: long-term electrical monitoring versus immediate anatomical and functional imaging.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Medtronic Reveal LINQ is designed for continuous ECG monitoring to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope. The Siemens ACUSON Sequoia Select is an advanced, AI-powered ultrasound system for diagnostic imaging across diverse patient populations and clinical applications, such as cardiology, gastroenterology, and radiology.
Reveal LINQ utilizes AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias and reduce false alerts. The ACUSON Sequoia Select integrates smart automation and AI-powered features like UltraArt for automatic image parameter settings, optimizing workflow and delivering personalized ultrasound imaging.
Reveal LINQ provides long-term, continuous ECG data for rhythm analysis and the detection of intermittent cardiac arrhythmias. The ACUSON Sequoia Select offers real-time, high-resolution ultrasound imaging for structural and functional assessment of the heart and other organs, including advanced features like Virtual Touchu2122 Elastography and Contrast Enhanced Ultrasound (CEUS).
Reveal LINQ offers wireless data transmission to the CareLinku2122 network via the MyCareLinku2122 Patient Monitor. Clinicians can also manage the device using the Reveal LINQu2122 Mobile Manager app, allowing for remote device management and data access.
Reveal LINQ is distinguished as the world's smallest insertable cardiac monitor, offering continuous ECG monitoring for up to three years with AccuRhythmu2122 AI algorithms for reduced false alerts. The ACUSON Sequoia Select features BioAcousticu2122 Imaging Technology for exceptional image quality and deeper penetration, along with specialized transducers like DAX for deep abdominal penetration up to 40cm.